Andy Nguyen
Internal Medicine · Salt Lake City, UTNPI 1033362694
Payments from drug & device makers
Across 24 payments — averaging $23.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$152
- Novartis$79
- Gilead$74
- Seagen Inc.$31
- Takeda Pharmaceuticals U.S.A., Inc.$29
- Jazz Pharmaceuticals Inc.$29
- plus $180 from 9 others
What the payments were for
- Food & beverage$47483%
- Education$10017%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 4 | $152 |
| Novartis | 1 | $79 |
| Gilead(2 entities) | 3 | $74 |
| Seagen Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Legend Biotech USA Inc. | 1 | $26 |
| Novo Nordisk | 1 | $25 |
| Pfizer | 2 | $24 |
| Amgen | 1 | $20 |
| Adaptive Biotechnologies Corporation | 1 | $20 |
| AbbVie | 1 | $18 |
| Grifols USA, LLC | 1 | $17 |
| Boston Scientific | 1 | $15 |
| Servier Pharmaceuticals LLC | 1 | $15 |
How this compares
$574 in reported general payments places this provider in the 65th percentile of 496 internal medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 15 | $270,103 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Salt Lake City
- Ahad SabetSalt Lake City$34.5M
- Willard DereSalt Lake City$4.7M
- Brandon WebbSalt Lake City$544K
- Larry StakerSalt Lake City$441K
- Alexander PastuszakSalt Lake City$197K
- Lowell BensonSalt Lake City$183K
- Gerald GleichSalt Lake City$119K
- James ChamberlainSalt Lake City$106K
- Zameer AbedinSalt Lake City$83K
- Brian HornerSalt Lake City$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.